Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2013, Article ID 687176, 4 pages
http://dx.doi.org/10.1155/2013/687176
Research Article

Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients

1Immunodeficiency Services, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA
2Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 285 Kapoor Hall, Buffalo, NY 14214, USA
3Translational Pharmacology Research Core, New York State Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14023, USA
4Infectious Disease Division, Department of Medicine, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA

Received 19 March 2013; Revised 12 June 2013; Accepted 29 June 2013

Academic Editor: D. A. Katzenstein

Copyright © 2013 James M. Mikula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

James M. Mikula, Chiu-Bin Hsiao, Joshua R. Sawyer, Qing Ma, and Gene D. Morse, “Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients,” AIDS Research and Treatment, vol. 2013, Article ID 687176, 4 pages, 2013. https://doi.org/10.1155/2013/687176.